JPS5695161U - - Google Patents

Info

Publication number
JPS5695161U
JPS5695161U JP17737179U JP17737179U JPS5695161U JP S5695161 U JPS5695161 U JP S5695161U JP 17737179 U JP17737179 U JP 17737179U JP 17737179 U JP17737179 U JP 17737179U JP S5695161 U JPS5695161 U JP S5695161U
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP17737179U
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP17737179U priority Critical patent/JPS5695161U/ja
Publication of JPS5695161U publication Critical patent/JPS5695161U/ja
Pending legal-status Critical Current

Links

JP17737179U 1979-12-20 1979-12-20 Pending JPS5695161U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP17737179U JPS5695161U (en) 1979-12-20 1979-12-20

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP17737179U JPS5695161U (en) 1979-12-20 1979-12-20

Publications (1)

Publication Number Publication Date
JPS5695161U true JPS5695161U (en) 1981-07-28

Family

ID=29687955

Family Applications (1)

Application Number Title Priority Date Filing Date
JP17737179U Pending JPS5695161U (en) 1979-12-20 1979-12-20

Country Status (1)

Country Link
JP (1) JPS5695161U (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8895556B2 (en) 2007-12-26 2014-11-25 Critical Outcome Technologies Inc. Compounds and method for treatment of cancer
US8987272B2 (en) 2010-04-01 2015-03-24 Critical Outcome Technologies Inc. Compounds and method for treatment of HIV
US9284275B2 (en) 2007-01-11 2016-03-15 Critical Outcome Technologies Inc. Inhibitor compounds and cancer treatment methods

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9284275B2 (en) 2007-01-11 2016-03-15 Critical Outcome Technologies Inc. Inhibitor compounds and cancer treatment methods
US8895556B2 (en) 2007-12-26 2014-11-25 Critical Outcome Technologies Inc. Compounds and method for treatment of cancer
US8987272B2 (en) 2010-04-01 2015-03-24 Critical Outcome Technologies Inc. Compounds and method for treatment of HIV
US9422282B2 (en) 2010-04-01 2016-08-23 Critical Outcome Technologies Inc. Compounds and method for treatment of HIV

Similar Documents

Publication Publication Date Title
FR2447120B1 (en)
DE3050184A1 (en)
FR2447198B1 (en)
BR8002583A (en)
DE3011023C2 (en)
DE3006534C2 (en)
BR8006808A (en)
DE3045424C2 (en)
FR2449098B1 (en)
FR2446855B1 (en)
DE3012842C2 (en)
FR2445744B1 (en)
DE3045017C2 (en)
FR2446260B1 (en)
JPS5695161U (en)
FR2436703B1 (en)
DE2937755C2 (en)
FR2447143B1 (en)
FR2447783B1 (en)
FR2448264B1 (en)
FR2446435B3 (en)
AT364253B (en)
BR5901094U (en)
AU78271S (en)
AU78385S (en)